Jefferies Starts Minerva Neurosciences (NERV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JMP Securities Starts Minerva Neurosciences (NERV) at Market Outperform
July 28, 2014 8:04 AM EDTJMP Securities initiated coverage on Minerva Neurosciences (NASDAQ: NERV) with a Market Outperform rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Minerva Neurosciences click here. For more ratings news on Minerva Neurosciences click here.
Shares of Minerva Neurosciences closed at $6.78 yesterday.
... MoreBaird Starts Minerva Neurosciences (NERV) at Outperform
July 28, 2014 7:31 AM EDTBaird initiates coverage on Minerva Neurosciences (NASDAQ: NERV) with a Outperform rating and a price target of $11.00.
Analyst Brian Skorney comments, "several shots on goal make Minerva an interesting opportunity, initiating at Outperform with an $11 price target. Despite the high inherent risk associated... More
